The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from the randomized phase III DREAMM-7 study of belantamab mafodotin (belamaf) + bortezomib, and dexamethasone (BVd) vs daratumumab, bortezomib, and dexamethasone (DVd) in relapsed/refractory multiple myeloma (RRMM).
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda
 
Pawel Robak
No Relationships to Disclose
 
Marek Hus
No Relationships to Disclose
 
Zhongjun Xia
No Relationships to Disclose
 
Vera Zherebtsova
No Relationships to Disclose
 
Christopher Ward
No Relationships to Disclose
 
P. Joy Ho
Honoraria - Drivetime Radio; Limbic Oncology
Consulting or Advisory Role - Antengene; BeiGene; Janssen
 
Roman Hajek
Honoraria - Amgen; Bristol Myers Squibb Foundation; Celgene; Janssen
Consulting or Advisory Role - ABBVIE/ABBOTT; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; PharmaMar; Takeda
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Takeda
 
Kihyun Kim
No Relationships to Disclose
 
Meletios A. Dimopoulos
Honoraria - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Sanofi; Takeda
 
Claudio Cerchione
Honoraria - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini; Pfizer; Sanofi/Aventis; SERVIER; Stemline Therapeutics; Takeda
Consulting or Advisory Role - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini; Pfizer; Sanofi; SERVIER; Stemline Therapeutics; Takeda
Speakers' Bureau - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini; Pfizer; Sanofi/Aventis; SERVIER; Stemline Therapeutics; Takeda
 
Antonio Riccio
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Astrid McKeown
Employment - Charles River Analytics (I); GlaxoSmithKline
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline; GlaxoSmithKline (I); HALEON; HALEON (I); Novartis; Novartis (I)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Rachel Rogers
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Hena Baig
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Lydia Eccersley
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Sumita Roy-Ghanta
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Joanna Opalinska
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Vania Hungria
Consulting or Advisory Role - ABBVIE/ABBOTT; Amgen; BMS GmbH & Co. KG; Celgene; GlaxoSmithKline; Janssen; Regeneron; Sanofi; Takeda